therapy

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung H-P, et al.. Failure of natalizumab to prevent relapses in neuromyelitis optica. Archives Neurology. 2012;69(2):239-45. DOI: 10.1001/archneurol.2011.216. PubMed PMID: 22332191.

Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes".

Mora S. Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes". Arch Intern Med. 2012;172(3):217-8. DOI: 10.1001/archinternmed.2011.626. PubMed PMID: 22231608.

Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come.

Aaronson DS, Odisho AY, Hills N, Cress R, Carroll PR, Dudley RA, et al. Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come. Arch Intern Med. 2012;172(3):280-3. DOI: 10.1001/archinternmed.2011.711. PubMed PMID: 22332166.

Supplemental oxygen therapy in medical emergencies: more harm than benefit?

Cornet AD, Kooter AJ, Peters MJL, Smulders YM. Supplemental oxygen therapy in medical emergencies: more harm than benefit?. Arch Intern Med. 2012;172(3):289-90. DOI: 10.1001/archinternmed.2011.624. PubMed PMID: 22231614.

Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.

Schwab N, Ulzheimer JC, Fox RJ, Schneider-Hohendorf T, Kieseier BC, Monoranu CM, et al. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology. 2012;78(7):458-67; discussion 465. DOI: 10.1212/WNL.0b013e3182478d4b. PubMed PMID: 22302546.

Efficacy and safety of deep brain stimulation as an adjunct to pharmacotherapy for the treatment of Parkinson disease.

Sharma A, Szeto K, Desilets AR. Efficacy and safety of deep brain stimulation as an adjunct to pharmacotherapy for the treatment of Parkinson disease. Ann Pharmacother. 2012;46(2):248-54. DOI: 10.1345/aph.1Q508. PubMed PMID: 22234991.

The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy.

Morgan KP, Buie LW, Savage SW. The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy. Ann Pharmacother. 2012;46(2):276-81. DOI: 10.1345/aph.1Q333. PubMed PMID: 22298599.

Cognitive behavior therapy for pediatric obsessive-compulsive disorder.

Wang Y. Cognitive behavior therapy for pediatric obsessive-compulsive disorder. Jama: J Am Med Assoc. 2012;307(6):560; author reply 560-1. DOI: 10.1001/jama.2012.108. PubMed PMID: 22318271.

Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation.

Ko S-B, Choi HA, Gilmore E, Schmidt JM, Claassen J, Lee K, et al. Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation. Neurology. 2012;78(6):e36-8. DOI: 10.1212/WNL.0b013e318245d270. PubMed PMID: 22311932.